We use cookies for a better user experience. Read our Privacy Policy

I Agree

Growing Trend of Early Vaccination of Pigs and Piglets Push Porcine Vaccines Market Valuation to US$ 3,208.8 Mn by 2025

Pharmaceutical |

Porcine vaccine is given to hogs or swine suffering from epidemic porcine diseases. Growing incidence of porcine epidemic diarrhea (PED), porcine reproductive and respiratory syndrome (PRRS) and swine flu in swine production farms across the globe has resulted in trend of early vaccination of pigs and piglets.

Besides protecting pigs from diseases and deadly viruses, the vaccine aids to improve overall production level of high-quality meat. The meat produced is fit for consumption.

In recent years, key players operating in the global porcine vaccines market are investing enormously in research and development of swine vaccines. Apart from them, stakeholders in the market are running awareness campaigns regarding porcine diseases and their prevention methods.

These factors, conjointly, are projected to boost demand for porcine vaccines across the globe in coming years. In addition, technological developments such as DNA vaccines and combined vaccine production would enable farmers to produce disease-free pigs. The factor is likely to propel porcine vaccines market forthcoming years.

As per a report published by Transparency Market Research, the global porcine vaccines market is likely to scale at a moderate CAGR of nearly 7.0% during the forecast period. In 2016, market size of global porcine vaccine market stood at a value equivalent to US$ 1,784.0 million. At the predicted CAGR, the market value is anticipated to reach US$ 3,208.8 Mn by the end of 2025.

global porcine vaccines market

Porcine Vaccines Market Witness High Investment Inflow for Research and Development of Vaccines

Owing to growing investment by stakeholders in the animal healthcare, increasing research and development activities to prevent porcine health concerns, rising incidence of swine fever, and upsurge in demand for porcine meat and gelatin are projected to propel the global porcine vaccine market during given forecast period.

Porcine vaccine is used as clinical drug as well. It has helped in improvement of health of swine and protects them against deadly viruses, pathogens, and deadly viruses. Diseases such as swine influenza, porcine reproductive and respiratory syndrome, diarrhea, and porcine circovirus associated disease (PCVAD) have been controlled from spreading in an epidemic manner.

North America Market May Observe Downturn of Growth Trajectory Due to Shift Towards Hog Production

With the help of vaccination, diseases such as cholera high fever and foot and mouth disease have been eradicated in swine in Europe and North America.

In 2016, North America market help prominent share in the global porcine vaccine market. However, the region may not remain prominent market during the forecast period. The vaccine is usually demanded in the region due to pig cultivation.  However, due to rise in infection of pigs due to PRRSV, PEDV, and PCV, hog production segment may grow during the forecast period.

Asia Pacific porcine vaccine market is estimated to exhibit progressive growth rate during the forecast period. China is likely to hold prominent share in Asia Pacific market.

Some of the companies operating in the global porcine vaccines market are Ceva Santé Animale, Boehringer Ingelheim GmbH, and Elanco (Eli Lilly and Company). Zoetis Inc. and Merck & Co. Inc. were prominent players in the global market in 2016. Zoetis Inc. was leading in the porcine vaccine market on back of its diverse product range and wide geographical presence. 

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact Us

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

Copyright © Transparency Market Research, Inc. All Rights reserved